Six updates for World Pneumonia Day
Click Here to Manage Email Alerts
Today marks World Pneumonia Day, a day during which the Forum of International Respiratory Societies, including the American Thoracic Society, raises awareness about the effect of this disease.
Pneumonia accounts for 16% of childhood deaths globally and is also a common cause of death or illness among the elderly, according to an ATS press release. However, the disease is largely preventable and treatable.
To honor World Pneumonia Day, Healio Pulmonology has compiled a list of the latest articles highlighting research in pneumonia.
New CAP guidelines stress de-escalation
Recently updated guidelines for the diagnosis and treatment of adults with community-associated pneumonia, or CAP, stressed the importance of de-escalation of antibiotic therapy and made stricter recommendations on when to use broad-spectrum antibiotics for the treatment of patients with CAP and risk factors for drug-resistant organisms. Read more
Prophylactic antibiotics decrease ventilator-associated pneumonia risk after cardiac arrest
A 2-day course of prophylactic antibiotic therapy lowered the incidence of early ventilator-associated pneumonia among patients treated with target temperature management after out-of-hospital cardiac arrest, according to results from the ANTHARTIC trial. Read more
Routine flu vaccination for adults hospitalized with pneumonia can reduce readmissions, mortality
NEW ORLEANS — In-hospital influenza vaccination may reduce 30-day readmissions, mortality, morbidity and health care resource utilization in adults with community-acquired pneumonia. Read more
Study identifies markers for pneumonia complications
Researchers have found three microRNAs that may predict respiratory failure and sepsis among patients with community-acquired pneumonia. Read more
How common is pneumococcal urinary antigen testing?
Despite guidelines recommending its use, pneumococcal urinary antigen testing, or UAT, is not performed often in the United States, even though it can help identify patients who are eligible for antibiotic de-escalation, researchers reported. Read more
Pneumocystis pneumonia incidence in rheumatic disease dependent upon risk factors
Concomitant steroid-pulse treatment and baseline lymphopenia were among risk factors for pneumocystis pneumonia among a cohort of patients with rheumatic diseases receiving steroid treatment. Read more